05:50 , Jun 2, 2018 |  BioCentury  |  Product Development

Breaking from the herd

Behind the block of clinical studies on PD-1 and PD-L1 inhibitors, researchers are casting aside their herd mentality with a wide net of strategies to solve some of the most pressing problems in oncology, such...
07:00 , May 16, 2011 |  BioCentury  |  Emerging Company Profile

Andes: Reinstating Apoptosis

Andes Biotechnologies Inc. has discovered a new family of molecules, non-coding mitochondrial RNA, which are differentially expressed in cancer cells and appear to be involved in the apoptotic pathway. The company hopes that knocking down...